| MDS clinical diagnostic criteria for Parkinson's disease RB Postuma, D Berg, M Stern, W Poewe, CW Olanow, W Oertel, J Obeso, ... Movement Disorders 30 (12), 1591-1601, 2015 | 1233 | 2015 |
| Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up MC Rodriguez-Oroz, JA Obeso, AE Lang, JL Houeto, P Pollak, ... Brain 128 (10), 2240-2249, 2005 | 1061 | 2005 |
| Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease Deep-Brain Stimulation for Parkinson's Disease Study Group New England Journal of Medicine 345 (13), 956-963, 2001 | 934 | 2001 |
| Manual motor performance in a deafferented man JC Rothwell, MM Traub, BL Day, JA Obeso, PK Thomas, CD Marsden Brain 105 (3), 515-542, 1982 | 932 | 1982 |
| Pathophysiology of the basal ganglia in Parkinson's disease JA Obeso, MC Rodriguez-Oroz, M Rodriguez, JL Lanciego, J Artieda, ... Trends in neurosciences 23, S8-S19, 2000 | 804 | 2000 |
| The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease CD Marsden, JA Obeso Brain 117 (4), 877-897, 1994 | 795 | 1994 |
| Missing pieces in the Parkinson's disease puzzle JA Obeso, MC Rodriguez-Oroz, CG Goetz, C Marin, JH Kordower, ... Nature medicine 16 (6), 653-661, 2010 | 709 | 2010 |
| Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms MC Rodriguez-Oroz, M Jahanshahi, P Krack, I Litvan, R Macias, E Bezard, ... The Lancet Neurology 8 (12), 1128-1139, 2009 | 685 | 2009 |
| Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease P Redgrave, M Rodriguez, Y Smith, MC Rodriguez-Oroz, S Lehericy, ... Nature Reviews Neuroscience 11 (11), 760-772, 2010 | 673 | 2010 |
| The anatomical basis of symptomatic hemidystonia CD Marsden, JA Obeso, JJ Zarranz, AE Lang Brain 108 (2), 463-483, 1985 | 664 | 1985 |
| Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease JA Obeso, MC Rodríguez‐Oroz, B Benitez‐Temino, FJ Blesa, J Guridi, ... Movement disorders: official journal of the Movement Disorder Society 23 (S3 …, 2008 | 512 | 2008 |
| Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications CW Olanow, JA Obeso, F Stocchi The Lancet Neurology 5 (8), 677-687, 2006 | 508 | 2006 |
| MDS research criteria for prodromal Parkinson's disease D Berg, RB Postuma, CH Adler, BR Bloem, P Chan, B Dubois, T Gasser, ... Movement Disorders 30 (12), 1600-1611, 2015 | 501 | 2015 |
| Levodopa motor complications in Parkinson's disease JA Obeso, CW Olanow, JG Nutt Trends in neurosciences 23, S2-S7, 2000 | 496 | 2000 |
| The impact of deep brain stimulation on executive function in Parkinson's disease M Jahanshahi, CMA Ardouin, RG Brown, JC Rothwell, J Obeso, ... Brain 123 (6), 1142-1154, 2000 | 452 | 2000 |
| The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics MC Rodriguez-Oroz, M Rodriguez, J Guridi, K Mewes, V Chockkman, ... Brain 124 (9), 1777-1790, 2001 | 451 | 2001 |
| Subthalamic nucleus‐mediated excitotoxicity in Parkinson's disease: a target for neuroprotection MC Rodriguez, JA Obeso, CW Olanow Annals of neurology 44 (S1 1), S175-S188, 1998 | 426 | 1998 |
| Temporal discrimination is abnormal in Parkinson's disease J Artieda, MA Pastor, F Lacruz, JA Obeso Brain 115 (1), 199-210, 1992 | 419 | 1992 |
| Levodopa in the treatment of Parkinson's disease: current controversies CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ... Movement disorders 19 (9), 997-1005, 2004 | 416 | 2004 |
| Reciprocal inhibition between the muscles of the human forearm. BL Day, CD Marsden, JA Obeso, JC Rothwell The Journal of physiology 349 (1), 519-534, 1984 | 399 | 1984 |
